Latest PCT Stories
Powertech Offers Strong Distribution and Support Network of 20 Offices/Laboratories, Over 60 Sales/Marketing/Service/Engineering Staff, and Multiple Sub-dealers Throughout China SOUTH
The Company Expects to Build and Ship Nine Instrument Systems for Evaluation between Mid-October and Late November.
ALLENDALE, N.J., July 18, 2011 /PRNewswire/ -- Progenitor Cell Therapy (PCT), an internationally recognized cell therapy services and development company, and a wholly-owned subsidiary of NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S.
SOUTH EASTON, Mass., Dec. 1 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc.